Literature DB >> 16635804

Consensus scoring for protein-ligand interactions.

Miklos Feher1.   

Abstract

This article reviews the application of consensus scoring for cases when the target 3D structure is known. Comparing the performance of different methods is not a trivial task, and it appears that consensus scoring usually substantially improves virtual screening performance, contributing to better enrichments. It also seems to improve--albeit less dramatically--the prediction of bound conformations and poses. The prediction of binding energies is still rather inaccurate and although consensus scoring generally improves these predictions, more development is required before it can be used for this purpose in routine lead optimization.

Mesh:

Substances:

Year:  2006        PMID: 16635804     DOI: 10.1016/j.drudis.2006.03.009

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  39 in total

1.  Virtual target screening: validation using kinase inhibitors.

Authors:  Daniel N Santiago; Yuri Pevzner; Ashley A Durand; MinhPhuong Tran; Rachel R Scheerer; Kenyon Daniel; Shen-Shu Sung; H Lee Woodcock; Wayne C Guida; Wesley H Brooks
Journal:  J Chem Inf Model       Date:  2012-07-23       Impact factor: 4.956

2.  Chemical space sampling by different scoring functions and crystal structures.

Authors:  Natasja Brooijmans; Christine Humblet
Journal:  J Comput Aided Mol Des       Date:  2010-04-18       Impact factor: 3.686

3.  Small molecule inhibitors of histone acetyltransferase Tip60.

Authors:  Jiang Wu; Juxian Wang; Minyong Li; Yutao Yang; Binghe Wang; Y George Zheng
Journal:  Bioorg Chem       Date:  2010-12-07       Impact factor: 5.275

Review 4.  Ligand discovery and virtual screening using the program LIDAEUS.

Authors:  P Taylor; E Blackburn; Y G Sheng; S Harding; K-Y Hsin; D Kan; S Shave; M D Walkinshaw
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

Review 5.  Computational methods in drug discovery.

Authors:  Gregory Sliwoski; Sandeepkumar Kothiwale; Jens Meiler; Edward W Lowe
Journal:  Pharmacol Rev       Date:  2013-12-31       Impact factor: 25.468

Review 6.  Receptor-ligand molecular docking.

Authors:  Isabella A Guedes; Camila S de Magalhães; Laurent E Dardenne
Journal:  Biophys Rev       Date:  2013-12-21

7.  A facile consensus ranking approach enhances virtual screening robustness and identifies a cell-active DYRK1α inhibitor.

Authors:  Maria E Mavrogeni; Filippos Pronios; Danae Zareifi; Sofia Vasilakaki; Olivier Lozach; Leonidas Alexopoulos; Laurent Meijer; Vassilios Myrianthopoulos; Emmanuel Mikros
Journal:  Future Med Chem       Date:  2018-10-16       Impact factor: 3.808

8.  Chemical validation of phosphodiesterase C as a chemotherapeutic target in Trypanosoma cruzi, the etiological agent of Chagas' disease.

Authors:  Sharon King-Keller; Minyong Li; Alyssa Smith; Shilong Zheng; Gurpreet Kaur; Xiaochuan Yang; Binghe Wang; Roberto Docampo
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

9.  Docking challenge: protein sampling and molecular docking performance.

Authors:  Khaled M Elokely; Robert J Doerksen
Journal:  J Chem Inf Model       Date:  2013-04-15       Impact factor: 4.956

10.  Target flexibility: an emerging consideration in drug discovery and design.

Authors:  Pietro Cozzini; Glen E Kellogg; Francesca Spyrakis; Donald J Abraham; Gabriele Costantino; Andrew Emerson; Francesca Fanelli; Holger Gohlke; Leslie A Kuhn; Garrett M Morris; Modesto Orozco; Thelma A Pertinhez; Menico Rizzi; Christoph A Sotriffer
Journal:  J Med Chem       Date:  2008-09-12       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.